22.07.2015 Views

Good Health Can’t Wait.

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Good</strong> <strong>Health</strong> <strong>Can’t</strong> <strong>Wait</strong>.<br />

Dr. Reddy’s Laboratories Limited<br />

19,800+<br />

Employees worldwide.<br />

(i) Preventable, (ii) Strategic and (iii)<br />

External risks. The Finance, Investment<br />

and Risk Management Council (or FIRM<br />

Council), is the Company’s management<br />

committee that helps the ERM function<br />

to prioritize organization-wide risks,<br />

review and steer mitigation efforts in line<br />

with the Company’s risk capacity and<br />

appetite. The FIRM council also oversees<br />

financial risk management and capital<br />

allocation decisions.<br />

REVIEWING THE STATUS OF<br />

MITIGATION AND RESIDUAL RISKS<br />

The Head of Dr. Reddy’s ERM team<br />

provides periodic updates to the FIRM<br />

Council and the Risk Committee of the<br />

Board of Directors. These include:<br />

(i) quarterly updates on the progress of<br />

mitigation of key risks, and (ii) specific<br />

initiatives carried out on risks during<br />

the year.<br />

During FY2015, the ERM team facilitated<br />

mitigation for certain geo-political and<br />

country risks, on forex and devaluation of<br />

currencies, on transfer risk and on people<br />

security. The team enhanced its key risk<br />

indicator tracking capabilities, developed<br />

a loss-data tracker and constructed a key<br />

learning’s summary for the year.<br />

On financial risk management, the team<br />

helped in developing a framework<br />

to enable making capital allocation<br />

decisions. It also assisted management<br />

in documentation and review of internal<br />

financial controls as required by the<br />

Companies Act, 2013.<br />

HUMAN RESOURCES<br />

Adjudged among the best employers<br />

in India, we at Dr. Reddy’s periodically<br />

renew our HR strategy to better engage<br />

with people and drive productivity across<br />

our 19,800-plus employees worldwide.<br />

Currently, our HR Strategy is designed to<br />

place our People Managers at the heart<br />

of all our employee practices. In this,<br />

we have stepped up our investments<br />

in leadership development and talent<br />

management programs.<br />

Our focus on leadership development<br />

and talent management was further<br />

strengthened this year. We continue to<br />

invest in our leadership development<br />

program which is built on the four tenets<br />

of ‘Lead Self, Lead Others, Lead Change<br />

and Lead Business’. The participants<br />

are beginning to show significant shifts<br />

in their development journey and the<br />

organization is benefiting through unique<br />

breakthrough projects that have been<br />

undertaken. We received CNBC ASIA’s<br />

India Talent Management Award this year<br />

as a recognition for our effective talent<br />

management practices.<br />

Dr. Reddy’s is an employer of choice<br />

for women. We lay special emphasis on<br />

helping our women colleagues grow<br />

professionally and personally as a part of<br />

our strategy to attract and retain the best<br />

talent in the industry. This year we made<br />

distinct progress in this area and rolled<br />

out our enabling policies and programs<br />

to help enhance gender diversity. Our<br />

focus on productivity also got an impetus<br />

as we benchmarked our productivity with<br />

industry and executed organizational<br />

design interventions that focused on<br />

delayering, reducing spans, sharply<br />

defining roles and agreeing on tighter<br />

manning norms. We also launched our<br />

new HR IT portal to help automate key<br />

HR processes.<br />

OUTLOOK<br />

The Company believes that its focus<br />

on profitable growth and targeting a<br />

leadership position in Global Generics<br />

and PSAI will create significant value in<br />

the near term.<br />

In GG, improving depth through<br />

portfolio expansion, cost leadership,<br />

consistent delivery of limited<br />

competition products and supply<br />

chain excellence should lead us to<br />

leadership positions in key markets. In<br />

PSAI, the objective is to be the partner<br />

of choice by creating compelling value<br />

52

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!